Literature DB >> 4739157

A subcutaneous reservoir for intrathecal therapy of fungal meningitis.

R D Diamond, J E Bennett.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4739157     DOI: 10.1056/NEJM197301252880405

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  15 in total

Review 1.  Adverse drug reactions to systemic antifungals. Prevention and management.

Authors:  J R Perfect; M H Lindsay; R H Drew
Journal:  Drug Saf       Date:  1992 Sep-Oct       Impact factor: 5.606

2.  Combination antifungal therapy for cryptococcal meningitis.

Authors:  J S Tobias; P F Wrigley; E Shaw
Journal:  Postgrad Med J       Date:  1976-05       Impact factor: 2.401

3.  Cerebral cryptococcosis in Malaysia.

Authors:  P M Richardson; A Mohandas; N Arumugasamy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-04       Impact factor: 10.154

Review 4.  Clinical pharmacokinetics of systemic antifungal drugs.

Authors:  T K Daneshmend; D W Warnock
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

5.  Management of central nervous system cryptococcosis.

Authors:  N Fujita; V Grinnell; J E Edwards; R A Feldman
Journal:  West J Med       Date:  1980-02

6.  Cryptococcal meningitis.

Authors:  T L Tjia; Y K Yeow; C B Tan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-09       Impact factor: 10.154

7.  Management of Increased Intracranial Pressure in Cryptococcal Meningitis.

Authors:  Kimberly J. Gambarin; Richard J. Hamill
Journal:  Curr Infect Dis Rep       Date:  2002-08       Impact factor: 3.725

Review 8.  Antifungal agents used in systemic mycoses. Activity and therapeutic use.

Authors:  J R Graybill; P C Craven
Journal:  Drugs       Date:  1983-01       Impact factor: 9.546

9.  Coccidioidal meningitis. Intrathecal treatment with hyperbaric amphotericin B.

Authors:  K P Glynn; N P Alazraki; T A Waltz
Journal:  Calif Med       Date:  1973-09

Review 10.  Management of infectious and immunological complications of acquired immunodeficiency syndrome (AIDS). Current and future prospects.

Authors:  C U Tuazon; A M Labriola
Journal:  Drugs       Date:  1987-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.